These findings suggested a mechanistic overlap between the Trop-2 signature and mutagenic/epigenetic PC driving changes, and supports a model of PC progression, through accumulation of genetic and epigenetic changes during tumor initiation, promotion and progression (62). The gene discussed is TACSTD2; the disease is neoplasm.